36 -

36 - Chu D, Lacouture ME, Weiner E, Wu S. Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis.[see comment]. Clin Genitourin Cancer. 2009;7(1):11-9.